What We’re Developing
Science-backed therapies for pets who need more
Gallant is developing ready-to-use stem cell therapies for conditions where current options fall short—targeting the root of disease and supporting the body’s natural healing response. These therapies are part of a new category of care, designed to restore function, not just manage symptoms.
Our Pipeline
Advancing regenerative therapies for pets in need
Every therapy in our pipeline advances through the FDA’s structured approval process—moving step-by-step through research, review, and clinical evaluation to meet rigorous standards for safety and quality.
| Pre-clinical |
proof of concept |
Controlled field study | Pivotal study | Commercially available | |
|---|---|---|---|---|---|
|
Feline Chronic Gingivostomatitis
|
|
||||
|
Canine Osteoarthritis
|
|
||||
|
Feline Chronic Kidney Disease
|
|
||||
|
Canine Atopic Dermatitis
|
|
||||
|
Feline Osteoarthritis
|
|
||||
Therapies in Development
Gallant is advancing a new class of veterinary therapeutics—ready-to-use stem cell therapies designed to address immune dysregulation and restore the body’s natural biological balance.
Administered intravenously and built for real-world veterinary practice, these therapies are being developed to target the root causes of disease, not just manage symptoms—offering a new pathway for conditions with limited or no effective treatment options.
These therapies are investigational and not available for general use, but may be accessible through participation in a clinical trial.
Feline Chronic Gingivostomatitis
Feline chronic gingivostomatitis (FCGS) is a painful oral disease that affects approximately 10% of cats and can be resistant to standard treatments. Gallant is evaluating a stem cell therapy designed to restore quality of life by addressing the underlying inflammation and promoting healing of oral lesions.
Feline Chronic Kidney Disease
Chronic kidney disease (CKD) is one of the most common and progressive conditions affecting older cats. Gallant’s investigational therapy is designed to target inflammation and support kidney health.
Canine Osteoarthritis
Osteoarthritis affects mobility, comfort, and daily activity in both young and older dogs. Gallant’s investigational therapy is designed to reduce inflammation and support joint health.
Feline Osteoarthritis
Osteoarthritis affects mobility, comfort, and daily activity, particularly in older cats, and is often underdiagnosed and undertreated. Gallant’s investigational therapy is designed to improve mobility and comfort by reducing inflammation and supporting joint repair.
Canine Atopic Dermatitis
Atopic dermatitis in dogs can cause chronic itching, skin damage, and discomfort. Gallant’s investigational therapy is designed to reduce inflammation and improve skin barrier function.
Want to participate in a study?
*All therapies are investigational and not yet FDA-approved
